Curis
CRIS
#10271
Rank
NZ$20.61 M
Marketcap
NZ$1.59
Share price
0.53%
Change (1 day)
-74.05%
Change (1 year)

Market capitalization of Curis (CRIS)

Market cap: NZ$20.61 Million

As of February 2026 Curis has a market cap of NZ$20.61 Million. This makes Curis the world's 10271th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Curis from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$20.61 M-12.9%
2025NZ$23.66 M-51.5%
2024NZ$48.79 M-58.94%
2023NZ$0.11 B42.3%
2022NZ$83.5 M-86.92%
2021NZ$0.63 B-36.32%
2020NZ$1.00 B1094.7%
2019NZ$83.9 M146.07%
2018NZ$34.09 M-78.9%
2017NZ$0.16 B-74.14%
2016NZ$0.62 B13.95%
2015NZ$0.54 B232.99%
2014NZ$0.16 B-44.1%
2013NZ$0.29 B-11.69%
2012NZ$0.33 B-27.35%
2011NZ$0.45 B132.97%
2010NZ$0.19 B-34.56%
2009NZ$0.30 B267.21%
2008NZ$82.02 M1.38%
2007NZ$80.91 M-8.3%
2006NZ$88.23 M-65.67%
2005NZ$0.25 B-26.07%
2004NZ$0.34 B23.8%
2003NZ$0.28 B349.4%
2002NZ$62.47 M-85.69%
2001NZ$0.43 B-30.51%
2000NZ$0.62 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Curis was reported to be:

NZ$20.5 Million
by Nasdaq info icon info icon
NZ$20.5 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$254.78 B 1,236,088.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$197.81 B 959,652.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$0.35 B 1,612.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$19.39 B 94,023.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$2.62 B 12,644.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$68.18 M 230.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.00 B 4,754.60%๐Ÿ‡บ๐Ÿ‡ธ USA